SCHEMBL459713

SCHEMBL459713

O=CCc1ccncc1F

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ LOXL2 Q9Y4K0 1/20 0.57
▸ KCNH3 Q9ULD8 1/20 0.40
▸ AOC1 P19801 4/20 0.35
▸ AOC3 Q16853 4/20 0.35
▸ NAMPT P43490 1/20 0.35
▸ GPR119 Q8TDV5 1/20 0.34
▸ BUB1 O43683 2/20 0.33
▸ CHRM1 P11229 3/20 0.32
▸ ADORA2A P29274 1/20 0.32
▸ ADORA1 P30542 1/20 0.32
▸ ERN1 O75460 1/20 0.31
▸ CYP2E1 P05181 1/20 0.31
▸ CYP2C8 P10632 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ CYP2A6 P11509 1/20 0.31
▸ CYP2B6 P20813 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ NUDT1 P36639 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29135614 0.77 — —
SCHEMBL805499 0.77 — —
SCHEMBL16671024 0.76 CYP2E1 (0.41) LOXL2AOC1AOC3CYP2E1CYP2C8
SCHEMBL4057138 0.76 SIRT3 (0.36) LOXL2AOC1AOC3GPR119BUB1
SCHEMBL3647173 0.76 ERN1 (0.40) LOXL2AOC1AOC3ERN1CYP2E1
SCHEMBL3914203 0.76 GAA (0.42) LOXL2AOC1AOC3CYP2E1CYP2C8
SCHEMBL16702897 0.76 AOC1 (0.59) LOXL2AOC1AOC3CYP2E1CYP2C8
SCHEMBL4051088 0.76 PARP1 (0.39) LOXL2AOC1AOC3CYP2E1CYP2C8
SCHEMBL12072719 0.72 — —
SCHEMBL3290073 0.72 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011147951-A1 CYCLOAMINO DERIVATIVES AS GPR119 ANTAGONISTS PROSIDION LIMITED (GB) 2011-12-01 — — WO disclosed
WO-2011056725-A1 PYRIDINE DERIVATIVES AND METHODS OF USE THEREOF CRYSTALGENOMICS, INC. (KR) 2011-05-12 — — WO disclosed
WO-2009114552-A1 HETEROARYL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE IN CANCER TREATMENT THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2009-09-17 — — WO disclosed
EP-2004623-A1 PYRIDYL- AND PYRIMIDINYL-SUBSTITUTED PYRROLE-, THIOPHENE- AND FURANE-DERIVATIVES AS KINASE INHIBITORS Nerviano Medical Sciences S.r.l. (IT) 2008-12-24 — — EP disclosed
WO-2007110344-A1 PYRIDYL- AND PYRIMIDINYL-SUBSTITUTED PYRROLE-, THIOPHENE- AND FURANE-DERIVATIVES AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2007-10-04 — — WO disclosed
Send feedback